How much is good enough? : Insights from myocardial infarction incidence during COVID-19 pandemic
(2021) In International Journal of Cardiology 334. p.24-25- Abstract
- The ongoing COVID-19 pandemic has radically changed the way we live and had an enormous impact on the global healthcare system [ [1]
]. Among many restrictions imposed on the societies, the national lockdowns have particularly disrupted the natural social networks and forced citizens to involuntary isolation. As a result, many patients have felt discouraged to visit their doctors, while emergency departments have been perceived as potentially hazardous zones that one should avoid. Inevitably, this must have influenced the epidemiology of common diseases, in which the appropriate recognition of symptoms and timely intervention is the key aspect of effective treatment. One of these medical emergencies is acute myocardial infarction... (More) - The ongoing COVID-19 pandemic has radically changed the way we live and had an enormous impact on the global healthcare system [ [1]
]. Among many restrictions imposed on the societies, the national lockdowns have particularly disrupted the natural social networks and forced citizens to involuntary isolation. As a result, many patients have felt discouraged to visit their doctors, while emergency departments have been perceived as potentially hazardous zones that one should avoid. Inevitably, this must have influenced the epidemiology of common diseases, in which the appropriate recognition of symptoms and timely intervention is the key aspect of effective treatment. One of these medical emergencies is acute myocardial infarction (AMI). In this issue, Rognoni and colleagues report on changes in admission rates due to AMI during the COVID-19 pandemic in Italy [ [2]
]. What they observed was a decline in AMI admissions during the national lockdown and partial return to the pre-lockdown admission rates during the first weeks after lockdown release. Interestingly, the post-lockdown return to normality was driven mainly by a distinct increase in hospitalizations related to non-ST-segment elevation MI (non-STEMI) but not due to STEMI. This study provides an important piece of information completing the landscape of cardiovascular disease development during COVID-19 pandemic and brings us some important insights. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/52b6e2e5-4871-4a7f-bafd-fcac911a6e62
- author
- Fedorowski, Artur LU and Erlinge, David LU
- organization
- publishing date
- 2021-07-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- International Journal of Cardiology
- volume
- 334
- pages
- 2 pages
- publisher
- Elsevier
- external identifiers
-
- pmid:33857541
- scopus:85104359704
- ISSN
- 0167-5273
- DOI
- 10.1016/j.ijcard.2021.04.020
- language
- English
- LU publication?
- yes
- id
- 52b6e2e5-4871-4a7f-bafd-fcac911a6e62
- date added to LUP
- 2021-04-16 10:42:45
- date last changed
- 2025-01-13 06:57:42
@misc{52b6e2e5-4871-4a7f-bafd-fcac911a6e62, abstract = {{The ongoing COVID-19 pandemic has radically changed the way we live and had an enormous impact on the global healthcare system [ [1]<br/>]. Among many restrictions imposed on the societies, the national lockdowns have particularly disrupted the natural social networks and forced citizens to involuntary isolation. As a result, many patients have felt discouraged to visit their doctors, while emergency departments have been perceived as potentially hazardous zones that one should avoid. Inevitably, this must have influenced the epidemiology of common diseases, in which the appropriate recognition of symptoms and timely intervention is the key aspect of effective treatment. One of these medical emergencies is acute myocardial infarction (AMI). In this issue, Rognoni and colleagues report on changes in admission rates due to AMI during the COVID-19 pandemic in Italy [ [2]<br/>]. What they observed was a decline in AMI admissions during the national lockdown and partial return to the pre-lockdown admission rates during the first weeks after lockdown release. Interestingly, the post-lockdown return to normality was driven mainly by a distinct increase in hospitalizations related to non-ST-segment elevation MI (non-STEMI) but not due to STEMI. This study provides an important piece of information completing the landscape of cardiovascular disease development during COVID-19 pandemic and brings us some important insights.}}, author = {{Fedorowski, Artur and Erlinge, David}}, issn = {{0167-5273}}, language = {{eng}}, month = {{07}}, pages = {{24--25}}, publisher = {{Elsevier}}, series = {{International Journal of Cardiology}}, title = {{How much is good enough? : Insights from myocardial infarction incidence during COVID-19 pandemic}}, url = {{http://dx.doi.org/10.1016/j.ijcard.2021.04.020}}, doi = {{10.1016/j.ijcard.2021.04.020}}, volume = {{334}}, year = {{2021}}, }